S1PR3 and myeloid sarcoma: Concerning S1P3 signaling in MS, Fischer et al., suggested that an increased expression of S1P3 in EAE was likely due to astrocyte activation; however, its actual sequelae regarding detrimental effects (e.g., astrogliosis) and beneficial effects (e.g., remyelination) could not be established [173].